Accendra Health annual gross margin
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Accendra Health's gross margin was 82.80% for fiscal 2024.
View full Accendra Health company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 82.80% | −0.45 pp |
| 2023 | 2023-12-31 | 83.26% | +64.91 pp |
| 2022 | 2022-12-31 | 18.35% | +2.88 pp |
| 2021 | 2021-12-31 | 15.46% | +0.36 pp |
| 2020 | 2020-12-31 | 15.10% | +2.85 pp |
| 2019 | 2019-12-31 | 12.25% | +0.89 pp |
| 2018 | 2018-12-31 | 11.37% | −1.21 pp |
| 2017 | 2017-12-31 | 12.58% | +0.37 pp |
| 2016 | 2016-12-31 | 12.21% | −0.22 pp |
| 2015 | 2015-12-31 | 12.43% | +0.03 pp |
| 2014 | 2014-12-31 | 12.39% | +0.08 pp |
| 2013 | 2013-12-31 | 12.31% | +1.89 pp |
| 2012 | 2012-12-31 | 10.43% | +0.49 pp |
| 2011 | 2011-12-31 | 9.94% | −0.00 pp |
| 2010 | 2010-12-31 | 9.94% | −0.19 pp |
| 2009 | 2009-12-31 | 10.13% | −0.10 pp |
| 2008 | 2008-12-31 | 10.23% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | 78.06% | +57.28 pp |
| Q3 2024 | 2024-09-30 | 81.49% | +61.22 pp |
| Q2 2024 | 2024-06-30 | 82.40% | +62.69 pp |
| Q1 2024 | 2024-03-31 | 20.50% | +4.54 pp |
| Q3 2023 | 2023-09-30 | 20.78% | +0.22 pp |
| Q2 2023 | 2023-06-30 | 20.26% | −1.04 pp |
| Q1 2023 | 2023-03-31 | 19.71% | +4.20 pp |
| Q4 2022 | 2022-12-31 | 15.96% | +2.11 pp |
| Q3 2022 | 2022-09-30 | 20.55% | +7.41 pp |
| Q2 2022 | 2022-06-30 | 21.30% | +5.23 pp |
| Q1 2022 | 2022-03-31 | 15.52% | −3.52 pp |
| Q4 2021 | 2021-12-31 | 13.84% | −3.03 pp |
| Q3 2021 | 2021-09-30 | 13.14% | −2.60 pp |
| Q2 2021 | 2021-06-30 | 16.07% | +1.17 pp |
| Q1 2021 | 2021-03-31 | 19.03% | +6.38 pp |
| Q4 2020 | 2020-12-31 | 16.87% | +3.88 pp |
| Q3 2020 | 2020-09-30 | 15.74% | +3.50 pp |
| Q2 2020 | 2020-06-30 | 14.90% | +2.85 pp |
| Q1 2020 | 2020-03-31 | 12.65% | +0.88 pp |
| Q4 2019 | 2019-12-31 | 13.00% | +9.78 pp |
| Q3 2019 | 2019-09-30 | 12.24% | −2.06 pp |
| Q2 2019 | 2019-06-30 | 12.06% | −1.17 pp |
| Q1 2019 | 2019-03-31 | 11.77% | −1.92 pp |
| Q4 2018 | 2018-12-31 | 3.22% | −9.97 pp |
| Q3 2018 | 2018-09-30 | 14.30% | +1.37 pp |
| Q2 2018 | 2018-06-30 | 13.22% | +1.15 pp |
| Q1 2018 | 2018-03-31 | 13.68% | +1.61 pp |
| Q4 2017 | 2017-12-31 | 13.19% | +0.73 pp |
| Q3 2017 | 2017-09-30 | 12.94% | +0.67 pp |
| Q2 2017 | 2017-06-30 | 12.07% | +0.02 pp |
| Q1 2017 | 2017-03-31 | 12.08% | −0.00 pp |
| Q4 2016 | 2016-12-31 | 12.45% | −0.10 pp |
| Q3 2016 | 2016-09-30 | 12.27% | −0.13 pp |
| Q2 2016 | 2016-06-30 | 12.06% | −0.26 pp |
| Q1 2016 | 2016-03-31 | 12.08% | −0.37 pp |
| Q4 2015 | 2015-12-31 | 12.55% | −0.05 pp |
| Q3 2015 | 2015-09-30 | 12.39% | +0.14 pp |
| Q2 2015 | 2015-06-30 | 12.32% | +0.08 pp |
| Q1 2015 | 2015-03-31 | 12.45% | −0.02 pp |
| Q4 2014 | 2014-12-31 | 12.60% | +0.04 pp |
| Q3 2014 | 2014-09-30 | 12.26% | +0.22 pp |
| Q2 2014 | 2014-06-30 | 12.24% | +0.01 pp |
| Q1 2014 | 2014-03-31 | 12.46% | +0.04 pp |
| Q4 2013 | 2013-12-31 | 12.56% | +0.71 pp |
| Q3 2013 | 2013-09-30 | 12.04% | +1.57 pp |
| Q2 2013 | 2013-06-30 | 12.23% | +2.55 pp |
| Q1 2013 | 2013-03-31 | 12.42% | +2.76 pp |
| Q4 2012 | 2012-12-31 | 11.85% | +2.10 pp |
| Q3 2012 | 2012-09-30 | 10.46% | +0.51 pp |
| Q2 2012 | 2012-06-30 | 9.67% | −0.46 pp |
| Q1 2012 | 2012-03-31 | 9.66% | −0.26 pp |
| Q4 2011 | 2011-12-31 | 9.75% | −0.29 pp |
| Q3 2011 | 2011-09-30 | 9.95% | +0.07 pp |
| Q2 2011 | 2011-06-30 | 10.14% | +0.29 pp |
| Q1 2011 | 2011-03-31 | 9.92% | −0.08 pp |
| Q4 2010 | 2010-12-31 | 10.04% | −0.00 pp |
| Q3 2010 | 2010-09-30 | 9.88% | +0.06 pp |
| Q2 2010 | 2010-06-30 | 9.85% | — |
| Q1 2010 | 2010-03-31 | 10.00% | — |
| Q3 2009 | 2009-09-30 | 10.04% | — |
| Q2 2009 | 2009-06-30 | 9.82% | — |
Over the last five reported fiscal years, Accendra Health's gross margin increased from 12.25% to 82.80%, a change of +70.55 percentage points. The latest reported quarter, Q1 2025, shows 78.06%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accendra Health filings at SEC.gov ↗